Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016 Jan;149(1):27-44.
doi: 10.1378/chest.15-1496. Epub 2016 Jan 6.

Treatment of Unexplained Chronic Cough: CHEST Guideline and Expert Panel Report

Peter Gibson  1 , Gang Wang  2 , Lorcan McGarvey  3 , Anne E Vertigan  4 , Kenneth W Altman  5 , Surinder S Birring  6 ; CHEST Expert Cough Panel
Collaborators, Affiliations
Review

Treatment of Unexplained Chronic Cough: CHEST Guideline and Expert Panel Report

Peter Gibson et al. Chest. 2016 Jan.

Abstract

Background: Unexplained chronic cough (UCC) causes significant impairments in quality of life. Effective assessment and treatment approaches are needed for UCC.

Methods: This systematic review of randomized controlled trials (RCTs) asked: What is the efficacy of treatment compared with usual care for cough severity, cough frequency, and cough-related quality of life in patients with UCC? Studies of adults and adolescents aged > 12 years with a chronic cough of > 8 weeks' duration that was unexplained after systematic investigation and treatment were included and assessed for relevance and quality. Based on the systematic review, guideline suggestions were developed and voted on by using the American College of Chest Physicians organization methodology.

Results: Eleven RCTs and five systematic reviews were included. The 11 RCTs reported data on 570 participants with chronic cough who received a variety of interventions. Study quality was high in 10 RCTs. The studies used an assortment of descriptors and assessments to identify UCC. Although gabapentin and morphine exhibited positive effects on cough-related quality of life, only gabapentin was supported as a treatment recommendation. Studies of inhaled corticosteroids (ICS) were affected by intervention fidelity bias; when this factor was addressed, ICS were found to be ineffective for UCC. Esomeprazole was ineffective for UCC without features of gastroesophageal acid reflux. Studies addressing nonacid gastroesophageal reflux disease were not identified. A multimodality speech pathology intervention improved cough severity.

Conclusions: The evidence supporting the diagnosis and management of UCC is limited. UCC requires further study to establish agreed terminology and the optimal methods of investigation using established criteria for intervention fidelity. Speech pathology-based cough suppression is suggested as a treatment option for UCC. This guideline presents suggestions for diagnosis and treatment based on the best available evidence and identifies gaps in our knowledge as well as areas for future research.

Keywords: chronic cough; cough frequency and severity; cough-related quality of life; treatment; unexplained cough.

PubMed Disclaimer

Figures

Figure 1
Figure 1
A proposed algorithm detailing a management approach to the patient with “difficult-to-treat” cough.
Figure 2
Figure 2
Systematic review flow diagram. Review Manager (RevMan) computer program. CENTRAL = Cochrane Central Register of Controlled Trials; PICO = population, intervention, comparison, outcome; RCT = randomized controlled trial.
Figure 3
Figure 3
A, Quality assessment for included RCTs, overall results. Version 5.2. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2012. B, Quality assessment for included RCTs, individual study results. Review Manager (RevMan) Version 5.2. Computer program. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2012. See Figure 2 legend for expansion of abbreviation.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Head J.R. Persistent cough of unexplained origin. Med Clin North Am. 1958;42(1):147–154. - PubMed
    1. Irwin R.S., Baumann M.H., Bolser D.C. Diagnosis and management of cough executive summary: ACCP evidence-based clinical practice guidelines. Chest. 2006;129(1 suppl):1S–23S. - PMC - PubMed
    1. Pratter M.R. Unexplained (idiopathic) cough: ACCP evidence-based clinical practice guidelines. Chest. 2006;129(supp 1):220S–221S. - PubMed
    1. Pavord I.D., Chung K.F. Management of chronic cough. Lancet. 2008;371(9621):1375–1384. - PubMed
    1. McGarvey L. The difficult-to-treat, therapy-resistant cough: why are current cough treatments not working and what can we do? Pulm Pharmacol Ther. 2013;26(5):528–531. - PubMed